![](https://cdn.prod.website-files.com/5f6e1c0200239d4debc07579/65c0eb5defcfe8e41cd823c4_jointechlabs-knee-circle.webp)
![](https://cdn.prod.website-files.com/5f6a09b2d5e6e4ea857ae242/6579ccd13daf961b28145820_rgnmed.com%20-%20open-circle%20-%20placeholder.webp)
Use of a Autologous MiniTC MFAT Injection to Improve Knee Pain and Function Among Patients with Osteoarthritis
Dr. Imran James Siddiqui
MD, Thomas Jefferson University
Dr. Imran James Siddiqui is board certified in both physical medicine and rehabilitation and musculoskeletal ultrasound. He is trained in cutting edge techniques in the diagnosis and treatment of joint, muscle and nerve conditions. In his practice, Dr. Siddiqui utilizes a patient-centered, holistic approach to healing with the objective of reducing pain, improving function, restoring health and preventing further injury.
This Circle is intended to evaluate the safety and efficacy of a single injection of autologous MiniTC MFAT for treatment of knee osteoarthritis. Application of the MiniTC technology can aid in the production of a clinically relevant cell enriched autologous microfat grafts for use in the healing of degenerative joint diseases. Over an 2-year period, this Circle captures patient-reported data related to knee pain, function, and stiffness prior to and following a one-time treatment of MiniTC MFAT.
Interventional
- Longitudinal, real-world safety and efficacy assessment of MFAT.
- Collaboration with nationally recognized musculoskeletal physicians.
- Clinically significant registry datasets supporting standards of care for a variety of lower extremity pathologies.
- Visual Analogue Scale (VAS)
- Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Private
![](https://cdn.prod.website-files.com/5f6e1c0200239d4debc07579/65c0eb5defcfe8e41cd823c4_jointechlabs-knee-circle.webp)
![](https://cdn.prod.website-files.com/5f6a09b2d5e6e4ea857ae242/6579ccd13daf961b28145820_rgnmed.com%20-%20open-circle%20-%20placeholder.webp)
Use of a Autologous MiniTC MFAT Injection to Improve Knee Pain and Function Among Patients with Osteoarthritis
This Circle is intended to evaluate the safety and efficacy of a single injection of autologous MiniTC MFAT for treatment of knee osteoarthritis. Application of the MiniTC technology can aid in the production of a clinically relevant cell enriched autologous microfat grafts for use in the healing of degenerative joint diseases. Over an 2-year period, this Circle captures patient-reported data related to knee pain, function, and stiffness prior to and following a one-time treatment of MiniTC MFAT.
VAS, WOMAC
- Longitudinal, real-world safety and efficacy assessment of MFAT.
- Collaboration with nationally recognized musculoskeletal physicians.
- Clinically significant registry datasets supporting standards of care for a variety of lower extremity pathologies.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Private